Pancreatic cancer only accounts for about 3% of cancers diagnosed in the U.S. each year, but it is the third most common cause of cancer-related death. Because the disease is often caught when it’s already at an advanced stage, MD Anderson researchers are exploring new ways to detect pancreatic cancer earlier, when patients are more likely to benefit from treatment.

We discussed new research on screening for pancreatic adenocarcinoma...